Borcoman, E.; Santana dos Santos, E.; Genestie, C.; Pautier, P.; Lacroix, L.; Caputo, S.M.; Cabaret, O.; Guillaud-Bataille, M.; Michels, J.; Auguste, A.;
et al. Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer. Int. J. Mol. Sci. 2023, 24, 11570.
https://doi.org/10.3390/ijms241411570
AMA Style
Borcoman E, Santana dos Santos E, Genestie C, Pautier P, Lacroix L, Caputo SM, Cabaret O, Guillaud-Bataille M, Michels J, Auguste A,
et al. Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer. International Journal of Molecular Sciences. 2023; 24(14):11570.
https://doi.org/10.3390/ijms241411570
Chicago/Turabian Style
Borcoman, Edith, Elizabeth Santana dos Santos, Catherine Genestie, Patricia Pautier, Ludovic Lacroix, Sandrine M. Caputo, Odile Cabaret, Marine Guillaud-Bataille, Judith Michels, Aurelie Auguste,
and et al. 2023. "Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer" International Journal of Molecular Sciences 24, no. 14: 11570.
https://doi.org/10.3390/ijms241411570
APA Style
Borcoman, E., Santana dos Santos, E., Genestie, C., Pautier, P., Lacroix, L., Caputo, S. M., Cabaret, O., Guillaud-Bataille, M., Michels, J., Auguste, A., Leary, A., & Rouleau, E.
(2023). Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer. International Journal of Molecular Sciences, 24(14), 11570.
https://doi.org/10.3390/ijms241411570
